State-of-the-Art Virology Research in Croatia 2022

Dear Colleagues,

Croatian scientists actively participate in fundamental studies of different viral pathogens, such as herpesviruses, adenoviruses, papillomaviruses, arboviruses, flaviviruses, rotaviruses, hantaviruses, and several others, with a focus on virology, viral immunology, pathogenesis, viral genetic diversity, and evolution. Furthermore, Croatian scientists’ research efforts also include developing novel viral and vaccine vectors, intensive investigations on papillomavirus-induced oncogenesis, and the molecular epidemiology of several human viral pathogens as well as investigations on viral zoonoses and the diversity of plant viruses and subviral pathogens and their impact on the ecosystems. In addition, Croatia is home to a scientific center of excellent repute dedicated to the study of virology: the Center of Excellence for Viral Immunology and Vaccines. The center hosts several research groups from the University of Rijeka and at the University of Zagreb and aims to become a vital facility for the further development of viral immunology and vaccinology in Croatia. The Center for Excellence's principal activities include studies on the basic mechanisms of virus control, viral evasion of the immune response, and the design of effective novel viral vaccines and vaccine vectors. Furthermore, following the emergence of the COVID-19 pandemic, significant activity in coronavirus research, supported mainly through the Croatian Science Foundation, has arisen in Croatia as well. The second edition of this Special Issue will provide an overview of research on virology and viral pathogenesis within the country. We are inviting colleagues to contribute reviews or original articles related to their research to this issue.

Prof. Dr. Stipan Jonjić
Dr. Dubravko Forčić
Dr. Andreja Ambriović-Ristov
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.